Can lithium be used in the setting of clozapine commencement in patients with <scp>COVID</scp>‐19 associated neutropenia: A case report-Reference-Cited by-同舟云学术

Can lithium be used in the setting of clozapine commencement in patients with COVID‐19 associated neutropenia: A case report

Published:2024-04 Issue:4 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Tan Jin Quan Eugene¹²^ORCID,Dawson Jessica L.¹³,Bastiampillai Tarun⁴⁵

Affiliation:

1. SA Pharmacy, Flinders Medical Centre Southern Adelaide Local Health Network Adelaide South Australia Australia

2. College of Medicine and Public Health Flinders University Adelaide South Australia Australia

3. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences Monash University Parkville Victoria Australia

4. Discipline of Psychiatry, College of Medicine and Public Health Flinders University Adelaide South Australia Australia

5. Department of Psychiatry Monash University Clayton Victoria Australia

Abstract

Key Clinical MessageCOVID‐19 infection may increase the likelihood of neutropenia in patients already on clozapine. In clozapine treated patients experiencing COVID‐19 associated neutropenia, adjunct therapy with lithium can be considered.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8758

Reference39 articles.

1. Clozapine prescribing barriers in the management of treatment-resistant schizophrenia

2. Clozapine-induced agranulocytosis

3. Meta-analysis examining the epidemiology of clozapine-associated neutropenia

4. Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study

5. Frequency of neutropenia over time in patients on clozapine;Govind R;medRxiv

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antipsychotics/sodium valproate;Reactions Weekly;2024-05-04